Skip to main content
AAO-HNSF 2023 Annual Meeting & OTO Experience Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Rate ePoster

Facial Plastic and Reconstructive Surgery

(118) Cost-Effectiveness Analysis of Liquid vs. Surgical Rhinoplasty

Monday, October 2, 2023
2:45 PM – 3:45 PM East Coast USA Time
Has Audio

    Presenting Author(s)

  • Jason Han Lee, MD

    Resident
    University of Mississippi Medical Center
    Jackson, Mississippi, United States

    • Co-Author(s)

  • AT

    Alia Tayara, Other

    Medical Student
    University of Mississippi Medical Center
    Jackson, Mississippi, United States

  • James D. Warren, BS

    Medical Student
    University of Mississippi Medical Center
    Jackson, Mississippi, United States

    • Senior Author(s)

  • JJ

    James R. Jordan, MD

    Professor
    University of Mississippi Medical Center
    Jackson, Mississippi, United States

Disclosure(s):
Jason Han Lee, MD: No relevant relationships to disclose.
James R. Jordan, MD: No relevant relationships to disclose.


Introduction: Filler injections for nonsurgical rhinoplasty have increased in popularity over the past decade, particularly among patients seeking to alter their nose's appearance with reduced risk, upfront cost, and downtime associated with traditional surgery.

Methods: A Markov model was used to analyze the cost-effectiveness of permanent surgical vs temporary liquid rhinoplasty lasting 1 year in adult patients, using the test case of a 30-year-old considering both options over 40 years. The cost assumptions were as follows: $15,000 for primary surgical and $2,000 for primary liquid rhinoplasty, as well as $10,000 for revision surgery and $1,000 for revision liquid rhinoplasty. The primary rhinoplasty revision rate was set as 5%, and revision rates for the other procedures were assumed to be 10%. These figures were derived from literature and expert opinion from the senior author. The primary outcome measures included individual and total costs, quality-adjusted life years (QALYs) using published health utility values, and incremental cost-effectiveness ratios (ICERs). The ICERs were evaluated against a published willingness-to-pay (WTP) threshold of $12,264 per QALY for surgical rhinoplasty.

Results: The average cost for liquid rhinoplasty was $68,297, while the average cost of surgical rhinoplasty was $18,260, assuming a one-time revision after one year to assess satisfaction. In terms of effectiveness, the average QALY gained for surgical rhinoplasty was 37.34, compared to 10.13 for liquid rhinoplasty. With respect to established literature, the ICER of $1,839 was well below the published WTP threshold.

Conclusions: To the best of our knowledge, this is the first study to assess QALY and cost-effectiveness of liquid versus surgical rhinoplasty. Our findings suggest that surgical rhinoplasty is both less costly and more effective than liquid rhinoplasty, falling within the acceptable cost-saving range. Further analysis incorporating complication rates and costs, post-operative recovery time, and variations in perioperative and operating room expenses will be conducted prior to final journal submission.